W hether we like it or not, nephrologists around the world have been called to action. Our mission is to attenuate the growth of chronic kidney disease (CKD). Several conditions will need to gel for us to succeed. Although we now have a better understanding of its alarming incidence and prevalence within populations, however we choose to define it, better methods are needed to identify at risk ...

Ana C. Ricardo, MD, MPH; Eileen Hacker, PhD, RN; Claudia M. Lora, MD; Lynn Ackerson, PhD; Karen B. DeSalvo, MD, MPH, MSc; Alan Go, MD; John W. Kusek, PhD; Lisa Nessel, MSS, MLSP; Akinlolu Ojo, MD; Raymond R. Townsend, MD; Dawei Xie, PhD; Carol E. Ferrans, PhD, RN; James P. Lash, MD, on behalf of the CRIC Investigators Objective: Evaluate the reliability and validity of the Kidney Disease Qualit...

Increasing evidence, accrued in the past decades, indicates that the adverse outcomes of chronic kidney disease, such as kidney failure, cardiovascular disease, and premature death, can be prevented or delayed. Earlier stages of chronic kidney disease can be detected through laboratory testing. Treatment of earlier stages of chronic kidney disease is effective in slowing the progression toward ...

36 Chronic kidney disease (CKD) affects an estimated 1% to 3% of all cats.1 This important cause of mortality in cats develops over a period of months or years. The associated nephron damage is progressive and irreversible even though some cats with CKD have stable serum creatinine concentrations for months to years. Diagnosis of early CKD, followed by appropriate treatment, may result in impro...

• Objective: To review clinical guideline recommendations for the identification and management of chronic kidney disease (CKD). • Methods: Qualitative assessment of the literature and review of current management guidelines. • Results: The incidence and prevalence of CKD is rising rapidly. Mortality rates are still unacceptably high despite improved technical and medical knowledge in the care ...